DOW INC
For the period ended Dec 31, 2023. Filed Jan 31, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Jan 31, 2024
DOW$31.48+1.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Equity
| (In millions, except per share amounts) For the years ended Dec 31, | 2023 | 2022 | 2021 |
|---|---|---|---|
| Common Stock | |||
| Balance at beginning and end of year | $— | $— | $— |
| Additional Paid-in Capital | |||
| Balance at beginning of year | 8,627 | 8,159 | 7,603 |
| Issuance of parent company stock - Dow Inc. | 188 | 212 | 320 |
| Stock-based compensation and allocation of ESOP shares | 276 | 258 | 236 |
| Other | — | (2) | — |
| Balance at end of year | 9,091 | 8,627 | 8,159 |
| Retained Earnings | |||
| Balance at beginning of year | 19,472 | 19,288 | 16,300 |
| Net income available for The Dow Chemical Company's common stockholder | 556 | 4,583 | 6,274 |
| Dividends to Dow Inc. | (2,510) | (4,375) | (3,264) |
| Other | (23) | (24) | (22) |
| Balance at end of year | 17,495 | 19,472 | 19,288 |
| Accumulated Other Comprehensive Loss | |||
| Balance at beginning of year | (7,139) | (8,977) | (10,855) |
| Other comprehensive income (loss) | (542) | 1,838 | 1,878 |
| Balance at end of year | (7,681) | (7,139) | (8,977) |
| Unearned ESOP Shares | |||
| Balance at beginning of year | — | (15) | (49) |
| Allocation of ESOP shares | — | 15 | 34 |
| Balance at end of year | — | — | (15) |
| The Dow Chemical Company's stockholder's equity | 18,905 | 20,960 | 18,455 |
| Noncontrolling Interests | 501 | 529 | 574 |
| Total Equity | $19,406 | $21,489 | $19,029 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.